Company research
JATT II Acquisition Corp.
CIK 2112446Updated Nov 10, 2026
SecurityJATT · NASDAQ · equity
JATT price & chart
Loading TradingView…
NASDAQ:JATT on TradingView ↗About the company
We are a blank check company incorporated on January 13, 2026, as a Cayman Islands exempted company with limited liability for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any potential business combination target with respect to our initial business combination.
In the news
No coverage from other publishers is available.
Seeking Alpha
U.S. IPO Weekly Recap: IPO Calendar Heats Up As AI Chipmaker Cerebras Rejoins The Public Pipeline ↗
U.S. IPO Weekly Recap: IPO Calendar Heats Up As AI Chipmaker Cerebras Rejoins The Public Pipeline ↗
SEC disclosures
Talawar Tx Inc. files merger communication (425) ↗
Recent filings
10-Q filing
DEFM14A filing
SCHEDULE 13D/A - filed by JATT Ventures II L.P. regarding JATT II Acquisition Corp.
SCHEDULE 13D - filed by JATT Ventures II L.P. regarding JATT II Acquisition Corp.
10-Q filing
Show 5 more recent filings
4 filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD Disclosure
Items 1.01, 3.02, 7.01, 9.01
10-Q filing
Other Events
Items 8.01, 9.01
4 filing
Offerings
Registration 333-294294
- Gross proceeds
- 60000000.0
- Net proceeds
- 57600000.0
- Deal price
- 10.0
- Shares
- 6000000
- Offering amount
- $60,000,000
- Offering price
- market-price
- Ticker
- JATT
Underwriters: Guggenheim Securities, LLC
Filing attachments
ea030601801ex99-1.htm · SCHEDULE 13D/A · 2026-09-18
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including any amendments thereto) with respect to the ordinary shares, $0.0001 par value, of JATT II Acquisition Corp, and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. The undersigned further agree that each party …
Read attachment ↗ea030561301ex99-1.htm · SCHEDULE 13D · 2026-09-15
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including any amendments thereto) with respect to the ordinary shares, $0.0001 par value, of JATT II Acquisition Corp, and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. The undersigned further agree that each party …
Read attachment ↗d136998dex991.htm · 8-K · 2026-06-29
EX-99.1 8 d136998dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases Oversubscribed $225 million concurrent private investment in public equity (“PIPE”) with available cash to the combined company at closing anticipated to fund TALA-125 through a Phase 2b proof-of-concept study data rea…
Read attachment ↗d136998dex992.htm · 8-K · 2026-06-29
EX-99.2 9 d136998dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 Corporate Presentation June 2026 Disclaimer and forward-looking statements This confidential presentation has been made available to you for informal purposes only with the consent of Talawar Tx Inc. (the “Company” or Talawar ) and JATT II Acquisition Corp (“JATT”) and has been prepared to assist interested parties in making their own evaluation wi th respect to a business combination between the Company and JATT and related transact…
Read attachment ↗ea028755501ex99-1.htm · 8-K · 2026-04-24
EX-99.1 2 ea028755501ex99-1.htm BALANCE SHEET DATED APRIL 20, 2026 Exhibit 99.1 JATT II ACQUISITION CORP INDEX TO FINANCIAL STATEMENT Page Financial Statement of JATT II Acquisition Corp: Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of April 20, 2026 F-3 Notes to Financial Statement F-4 F-1 REPORT OF INDEPENDENT REGISTERED …
Read attachment ↗ea028706601ex99-1.htm · 8-K · 2026-04-21
EX-99.1 9 ea028706601ex99-1.htm PRESS RELEASE, DATED APRIL 16, 2026 Exhibit 99.1 JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering Westfield, New Jersey, United States, April 16, 2026 (GLOBE NEWSWIRE) - JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00…
Read attachment ↗